Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients

Summary Objective To study the association of plasma 25-hydroxy vitamin D (25(OH)D) levels in HIV/HCV coinfected patients with severity of liver disease and virological response to hepatitis C virus (HCV) therapy with pegylated-interferon-alpha plus ribavirin (pegIFNα/RBV). Methods A cross-sectional...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infection 2014-02, Vol.68 (2), p.176-184
Hauptverfasser: Guzmán-Fulgencio, María, García-Álvarez, Mónica, Berenguer, Juan, Jiménez-Sousa, Mª Ángeles, Cosín, Jaime, Pineda-Tenor, Daniel, Carrero, Ana, Aldámiz, Teresa, Álvarez, Emilio, López, Juan Carlos, Resino, Salvador
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary Objective To study the association of plasma 25-hydroxy vitamin D (25(OH)D) levels in HIV/HCV coinfected patients with severity of liver disease and virological response to hepatitis C virus (HCV) therapy with pegylated-interferon-alpha plus ribavirin (pegIFNα/RBV). Methods A cross-sectional study in 174 HIV/HCV coinfected patients that underwent a liver biopsy previously to start HCV therapy and a retrospective study of 125 of them. Plasma 25(OH)D levels were quantified by enzyme immunoassay. Liver biopsies were evaluated by METAVIR score. A sustained virological response (SVR) was defined as an undetectable serum HCV viral load (
ISSN:0163-4453
1532-2742
DOI:10.1016/j.jinf.2013.10.011